These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer. To KK; Leung WW; Ng SS Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386 [TBL] [Abstract][Full Text] [Related]
3. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer. Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530 [TBL] [Abstract][Full Text] [Related]
4. miR-372 and miR-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways. Wang LQ; Yu P; Li B; Guo YH; Liang ZR; Zheng LL; Yang JH; Xu H; Liu S; Zheng LS; Zhou H; Qu LH Mol Oncol; 2018 Nov; 12(11):1949-1964. PubMed ID: 30171794 [TBL] [Abstract][Full Text] [Related]
5. Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2. Xie ZY; Liu MS; Zhang C; Cai PC; Xiao ZH; Wang FF Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30120100 [No Abstract] [Full Text] [Related]
6. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells. Shi L; Xi J; Xu X; Peng B; Zhang B Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544 [TBL] [Abstract][Full Text] [Related]
7. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1. Park YR; Seo SY; Kim SL; Zhu SM; Chun S; Oh JM; Lee MR; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135139 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-143 inhibits colorectal cancer cell proliferation by targeting MMP7. Yu B; Liu X; Chang H Minerva Med; 2017 Feb; 108(1):13-19. PubMed ID: 27827523 [TBL] [Abstract][Full Text] [Related]
9. Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells. Li X; Pan YZ; Seigel GM; Hu ZH; Huang M; Yu AM Biochem Pharmacol; 2011 Mar; 81(6):783-92. PubMed ID: 21219875 [TBL] [Abstract][Full Text] [Related]
10. miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2. Shi L; Wang Z; Sun G; Wan Y; Guo J; Fu X Neuromolecular Med; 2014 Jun; 16(2):517-28. PubMed ID: 24777293 [TBL] [Abstract][Full Text] [Related]
11. Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling. Hepburn AC; Veeratterapillay R; Williamson SC; El-Sherif A; Sahay N; Thomas HD; Mantilla A; Pickard RS; Robson CN; Heer R PLoS One; 2012; 7(11):e50690. PubMed ID: 23226356 [TBL] [Abstract][Full Text] [Related]
12. The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation. Jones MF; Hara T; Francis P; Li XL; Bilke S; Zhu Y; Pineda M; Subramanian M; Bodmer WF; Lal A Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1550-8. PubMed ID: 25775580 [TBL] [Abstract][Full Text] [Related]
13. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential. Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090 [TBL] [Abstract][Full Text] [Related]
14. Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer. Chen J; Chen S; Zhuo L; Zhu Y; Zheng H Cell Death Dis; 2020 Mar; 11(3):173. PubMed ID: 32144236 [TBL] [Abstract][Full Text] [Related]
15. Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer. Zhao Y; Zhao L; Ischenko I; Bao Q; Schwarz B; Nieß H; Wang Y; Renner A; Mysliwietz J; Jauch KW; Nelson PJ; Ellwart JW; Bruns CJ; Camaj P Target Oncol; 2015 Dec; 10(4):535-48. PubMed ID: 25639539 [TBL] [Abstract][Full Text] [Related]
16. Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1. Xie ZY; Wang FF; Xiao ZH; Liu SF; Tang SL; Lai YL J Biochem; 2020 Jun; 167(6):557-564. PubMed ID: 32044957 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer. Park YR; Lee ST; Kim SL; Liu YC; Lee MR; Shin JH; Seo SY; Kim SH; Kim IH; Lee SO; Kim SW Int J Oncol; 2016 May; 48(5):2135-43. PubMed ID: 26983891 [TBL] [Abstract][Full Text] [Related]
18. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L. Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells. Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553 [TBL] [Abstract][Full Text] [Related]
20. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer. Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]